09/12/2024
11:15 PM | Akebia Therapeutics (Filer)
| Form EFFECT | |
08/08/2024
6:52 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:06 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
5:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:31 PM | Akebia Therapeutics (Issuer)
Akebia Therapeutics (Issuer)
Ostrowski Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
4:37 PM | Akebia Therapeutics (Issuer)
Ostrowski Erik (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2024
8:03 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/10/2024
3:18 PM | ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:18 PM | Akebia Therapeutics (Issuer)
ZUMWALT LEANNE M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:19 PM | Akebia Therapeutics (Issuer)
FRIESON RON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:19 PM | Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:19 PM | Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:20 PM | Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:20 PM | Akebia Therapeutics (Issuer)
Wolf Myles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:04 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:05 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
6:17 PM | Akebia Therapeutics (Subject)
Hadas Nicole R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
6:19 PM | Akebia Therapeutics (Subject)
Dahan Michel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
4:27 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:03 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:05 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
4:17 PM | Akebia Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
4:18 PM | Akebia Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
4:19 PM | Akebia Therapeutics (Filer)
| Form ARS | |
04/23/2024
7:32 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
6:33 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
4:19 PM | Akebia Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2024
4:48 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:49 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:46 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:47 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:00 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:01 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:02 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:03 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:32 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:11 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:14 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:16 PM | Akebia Therapeutics (Subject)
Dahan Michel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:19 PM | Akebia Therapeutics (Subject)
Hadas Nicole R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:00 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Kamala Harris To Tank the Market? (Ad) URGENT ELECTION MELTDOWN WARNING
From the former CIA advisor who predicted President Trump’s win in 2016… Click here now to see how to protect yourself. |
02/01/2024
3:52 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
3:40 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
7:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
4:21 PM | Akebia Therapeutics (Issuer)
Grund Nicholas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/18/2024
3:21 PM | Akebia Therapeutics (Issuer)
Malabre Richard C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2024
7:02 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
4:07 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
6:45 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:33 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:34 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
7:31 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:47 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
